Lista de obras - Pieter Gillard - Dominio Público Uruguay

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

artículo científico publicado en 2020

Accuracy and Precision of Flash Glucose Monitoring Sensors Inserted Into the Abdomen and Upper Thigh Compared to the Upper Arm (out of sight).

artículo científico publicado en 2018

Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression

artículo científico publicado en 2016

Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation

artículo científico publicado en 2008

Arresting type 1 diabetes after diagnosis: GAD is not enough

artículo científico publicado en 2011

Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes

artículo científico publicado en 2014

Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.

artículo científico publicado en 2010

Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance

artículo científico publicado en 2004

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation

artículo científico publicado en 2008

Cholestatic liver disease in long-term infantile nephropathic cystinosis

artículo científico publicado en 2008

Comparative evaluation of simple indices of graft function after islet transplantation

artículo científico publicado en 2011

Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts

artículo científico publicado en 2008

Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio

artículo científico publicado en 2017

Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

artículo científico publicado en 2006

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients

scientific article published on 14 July 2009

Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus

artículo científico publicado en 2016

Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy

artículo científico publicado en 2014

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions and Quality of Life: A Real-World Study

artículo científico publicado en 2018

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

artículo científico publicado en 2018

Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts

artículo científico publicado en 2005

Formation of Amyloid in Encapsulated Human Pancreatic and Human Stem Cell-Generated Beta Cell Implants

artículo científico publicado en 2020

Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients

artículo científico publicado en 2009

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Soc

artículo científico publicado en 2020

Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies

scientific article published on 23 June 2009

HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft

artículo científico publicado en 2016

Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC.

artículo científico publicado en 2015

Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.

artículo científico publicado en 2014

Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient.

artículo científico publicado en 2016

Immune and cell therapy in type 1 diabetes: too little too late? ⬇️

artículo científico publicado el 15 de marzo de 2011

Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects

artículo científico publicado en 2012

In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A24 and HLA-B18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions

artículo científico publicado en 2013

Insulin analogues in type 1 diabetes mellitus: getting better all the time

artículo científico publicado en 2017

Insulitis and lymphoid structures in the islets of Langerhans of a 66-year-old patient with long-standing type 1 diabetes

scientific article published on 24 August 2020

Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes

artículo científico publicado en 2020

Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.

artículo científico publicado en 2013

Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort Study

artículo científico publicado en 2015

No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes

artículo científico publicado en 2020

Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study

artículo científico publicado en 2019

Otelixizumab in the treatment of type 1 diabetes mellitus

artículo científico publicado en 2011

Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

artículo científico publicado en 2015

Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation

artículo científico publicado en 2006

Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.

artículo científico publicado en 2016

Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.

artículo científico publicado en 2013

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

scientific article published on 16 December 2019

Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation

artículo científico publicado en 2009

SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients

artículo científico publicado en 2018

Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients

artículo científico publicado en 2013

Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes

artículo científico publicado en 2016

Stem-cell-based Therapies for Improving Islet Transplantation Outcomes in Type 1 Diabetes

artículo científico publicado en 2018

Sustained Impact of Real-Time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study

scientific article published on 16 October 2020

Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient

scientific article published on 26 April 2013

Lista de obras de Pieter Gillard

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

Accuracy and Precision of Flash Glucose Monitoring Sensors Inserted Into the Abdomen and Upper Thigh Compared to the Upper Arm (out of sight).

Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression

Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation

Arresting type 1 diabetes after diagnosis: GAD is not enough

Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes

Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.

Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation

Cholestatic liver disease in long-term infantile nephropathic cystinosis

Comparative evaluation of simple indices of graft function after islet transplantation

Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts

Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio

Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients

Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus

Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions and Quality of Life: A Real-World Study

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts

Formation of Amyloid in Encapsulated Human Pancreatic and Human Stem Cell-Generated Beta Cell Implants

Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Soc

Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies

HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft

Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC.

Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.

Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient.

Immune and cell therapy in type 1 diabetes: too little too late? ⬇️

Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects

In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions

Insulin analogues in type 1 diabetes mellitus: getting better all the time

Insulitis and lymphoid structures in the islets of Langerhans of a 66-year-old patient with long-standing type 1 diabetes

Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes

Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.

Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort Study

No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes

Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study

Otelixizumab in the treatment of type 1 diabetes mellitus

Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation

Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.

Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation

SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients

Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients

Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes

Stem-cell-based Therapies for Improving Islet Transplantation Outcomes in Type 1 Diabetes

Sustained Impact of Real-Time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study

Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient

In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A24 and HLA-B18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions